Brief: QIAGEN And Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test
May 31 (Reuters) - QIAGEN NV QIA.DE :
* SAID ON THURSDAY: QIAGEN AND MYRIAD GENETICS DEVELOP
DISTRIBUTABLE HOMOLOGOUS RECOMBINATION DEFICIENCY TEST FOR
GLOBAL RESEARCH AND COMPANION DIAGNOSTICS APPLICATIONS
Further company coverage: QIA.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))